A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

Clinical trial NCT07214376 · RECRUITING

Trial details

NCT number: NCT07214376
Sponsor: Pulnovo Medical, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pulmonary Hypertension Heart Failure With Reduced Ejection Fraction Hypertension Vascular Diseases Cardiovascular Diseases Heart Failure Heart Failure With Preserved Ejection Fraction Heart Failure With Mid Range Ejection Fraction

Start date: 2026-07-30
Primary completion: 2029-12-31
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.